CCND1 and CDKN1B polymorphisms and risk of breast cancer

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 3093-3098

  Canbay, Emel ^a   Eraltan, Ilhan Yaylim ^b   Ali, Cercel ^c   Isbir, Turgay ^b   Gazioglu, Ertugrul ^c   Aydogan, Fatih ^c   Cacina, Canan ^b   Ali, Cengiz ^c   Ferahman, Mehmet ^c   Zengin, Emel ^c   Unal, Hilal ^c  

^a Basaksehir State Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Breast cancer; CDKN1B polymorphism; Cyclin D polymorphism; Turkish population

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CYCLIN D1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77955835352     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 5: 225-249, 2009.
2. Peters MG, Vidal Mdel C, Giménez L, Maura L, Armanasco E, Cresta C, Bal de Kier Joffé E and Puricelli L: Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer. Oncol Rep. 12(5): 1143-1150, 2004.
3. Ormandy CJ, Musgrove EA, Hui R, Daly RJ and Sutherland RL: Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 78(3): 323-335, 2003.
4. Radu A, Neubauer V, Akagi T, Hanafusa H and Georgescu MM: PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol 23(17): 6139-6149, 2003. (Pubitemid 37013092)
5. Sutherland RL and Musgrove EA: Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models. Breast Cancer Res 4: 14-17, 2002. (Pubitemid 34097551)
6. Alle KM, Henshall SM, Field AS and Sutherland RL: Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res. 4(4): 847-854, 1998. (Pubitemid 28183384)
7. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD and Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011,1995.
8. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, Hara M and Saito I: Alternatively spliced forms of Cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16(13): 1701-1712, 1998. (Pubitemid 28175051)
9. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ and Knudsen ES: cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278(32): 30339-30347, 2003. (Pubitemid 36962428)
10. Lu F, Gladden AB and Diehl JA: An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 63(21): 7056-7061, 2003. (Pubitemid 37413439)
11. Grieu F, Malaney S, Ward R, Joseph D and Iacopetta B: Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res 23(5b): 4257-4259, 2003. (Pubitemid 37474930)
12. Shu XO, Moore DB, Cai Q, Cheng J, Wen W, Pierce L, Cai H, Gao YT and Zheng W: Association of cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev 14(1): 91-97, 2005. (Pubitemid 40165288)
13. Ceschi M, Sun CL, Van Den Berg D, Koh WP, Yu MC and Probst-Hensch N: The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis 26(8): 1457-1464, 2005. (Pubitemid 41417890)
14. Yu CP, Yu JC, Sun CA, Tzao C, Ho JY and Yen AM: Tumour susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1. Breast Cancer Res Treat. 107(1): 95-102, 2008. (Pubitemid 350179583)
15. Försti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K and Kumar R: Single nucleotide polymorphisms in breast cancer. Oncol Rep 11(4): 917-922, 2004.
16. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W, Leithner A and Samonigg H: The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat 82(3): 165-168, 2003.
17. Onay UV, Aaltonen K, Briollais L, Knight JA, Pabalan N, Kilpivaara O, Andrulis IL, Blomqvist C, Nevanlinna H and Ozcelik H: Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk. BMC Cancer 8: 6, 2008.
18. Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK and Dowdy SF: Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol 21(14): 4773-4784, 2001. (Pubitemid 32588257)
19. 1-phase progression. Genes Dev 13: 1501-1512, 1999.
20. Alkarain A and Slingerland J: Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Res 6: 13-21, 2004. (Pubitemid 38195556)
21. Schöndorf T, Eisele L, Göhring UJ, Valter MM, Warm M, Mallmann P, Becker M, Fechteler R, Weisshaar MP and Hoopmann M: The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients. Tumour Biol 25(5-6): 306-312, 2004.
22. Ma H, Jin G, Hu Z, Zhai X, Chen W, Wang S, Wang X, Qin J, Gao J, Liu J, Wang X, Wei Q and Shen H: Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Int J Cancer 119(9): 2173-2178, 2006.
23. Miller SA, Dykes DD and Polesky HF: Simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
24. Lewis RC, Bostick RM, Xie D, Deng Z, Wargovich MJ, Fina MF, Roufail WM and Geisinger KR: Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 63(23): 8549-8553, 2003.
25. Naidu R, Yip CH and Taib NA: Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases. Neoplasma 55: 87-95, 2008.
26. Justenhoven C, Pierl CB, Haas S, Fischer HP, Hamann U, Baisch C, Harth V, Spickenheuer A, Rabstein S, Vollmert C, Illig T, Pesch B, Brüning T, Dippon J, Ko YD and Brauch H: Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors. Int J Cancer 124(9): 2077-2081, 2009.
27. Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O and Ozcelik H: Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(10): 2773-2781, 2008.
28. Mavaddat N, Dunning AM, Ponder BA, Easton DF and Pharoah PD: Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. Cancer Epidemiol Biomarkers Prev 18(1): 255-259, 2009.
29. Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, Tyrer JP, Ponder BA,Saston DF, Pharoah PD and Dunning AM; Studies in Epidemiology and Risks of Cancer Heredity (SEARCH) Team. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29(2): 333-341, 2008.
30. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M and Sellers WR: Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20(23): 8969-8982, 2000. (Pubitemid 32245927)
31. Millard SS, Vidal A, Markus M and Koff A: A U-rich element in the 5′ untranslated region is necessary for the translation of p27 mRNA. Mol Cell Biol 20: 5947-5959, 2000. (Pubitemid 30613044)
32. Kullmann M, Göpfert U, Siewe B and Hengst L: ELAV/Hu proteins inhibit p2T translation via an IRES element in the p27 5′UTR. Genes Dev 1 16(23): 3087-3099, 2002. (Pubitemid 35424195)